Business Description

Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) is a leader in precision medicine with immuno-targeted products designed to help identify the sites and pathways of undetected disease and enable better diagnostic accuracy, clinical decision-making, targeted treatment and, ultimately, patient care. Applying our Manocept™ technology, Navidea seeks to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases. The company, founded in 1983, maintains headquarters in Dublin, Ohio.

Company Info

Address:
4100 Horizons Drive
Suite 205
Columbus, OH 43220

Toll Free:
800-793-0079

Telephone:
614-793-7500

Fax:
614-793-7520

Email:
investorrelations@navidea.com

Industry Classifications

Sector:
Healthcare

Industry:
Biotechnology

NAICS:
In-Vitro Diagnostic Substance Manufacturing (325413)

SIC:
In Vitro and In Vivo Diagnostic Substances (2835)